Opportunity Information: Apply for PA 08 126
Apply for PA 08 126
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Epidemiology Of Drug Abuse (R03)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Dec 5, 2008 and posted on Mar 28, 2008.
- Applicants must submit their applications by May 7, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Private institutions of higher education County governments City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts Others (see text field entitled Additional Information on Eligibility for clarification) Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments For profit organizations other than small businesses State governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Epidemiology of Drug Abuse (R03) opportunity (Funding Opportunity Number PA-08-126) was a National Institute on Drug Abuse (NIDA), NIH funding announcement designed to support small, focused epidemiologic studies that improve understanding of drug abuse in real-world populations. The central aim was to expand and strengthen epidemiologic research that clarifies the nature and extent of drug use and drug use disorders, their consequences, and their causes (etiology). The scope is broad and explicitly population-oriented, encouraging work that looks across individuals and families as well as differences by age group, gender, community context, and other population subgroups. In practical terms, the program was looking for research that can sharpen knowledge about patterns of use, risk and protective factors, trajectories over time, and the public health burden of drug abuse, with attention to how these issues vary across different settings and groups.
The award mechanism was the NIH Small Research Grant (R03), which is intended for short-term projects that can be completed with limited resources. The announcement emphasizes that R03 projects can take several common forms, including pilot and feasibility studies, secondary analyses of existing datasets, small self-contained research projects, and efforts focused on developing or refining research methods or new research technology relevant to drug abuse epidemiology. This matters because it signals the kind of work NIDA expected: projects that are tightly scoped, efficient, and likely to generate useful findings quickly, either by testing an idea before a larger study, extracting new insights from data that already exist, or improving the tools used to measure and analyze drug-related outcomes in populations.
This R03 announcement ran in parallel with two companion announcements that shared the same scientific scope but offered different grant mechanisms: an R01 version (PA-08-124) for larger, more comprehensive projects, and an R21 version (PA-08-125) for exploratory or developmental work. That structure gave applicants multiple routes depending on project size, maturity, and resource needs, while keeping the underlying research goals aligned across mechanisms.
Funding levels and the number of awards were not specified as fixed amounts because NIDA expected proposals to vary widely in topic, design, duration, and budget needs. As a result, the agency indicated that award sizes and project periods would vary, and that final funding decisions would depend on the number of applications received, their scientific and technical quality, requested duration, and proposed costs. There was no cost sharing or matching requirement.
Eligibility was broad and included many organization types across the public, private, nonprofit, and governmental spectrum. Eligible applicants included public and private institutions of higher education, nonprofits with and without 501(c)(3) status, small businesses, for-profit organizations (other than small businesses), state and local governments (including counties, cities/townships, special districts), independent school districts, public housing authorities/Indian housing authorities, Native American tribal governments and tribal organizations, and additional categories such as HBCUs, Hispanic-serving institutions, tribally controlled colleges and universities, Alaska Native and Native Hawaiian serving institutions, faith-based and community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions. The announcement also allowed non-U.S. (foreign) organizations to apply, reflecting the relevance of drug abuse epidemiology to global as well as domestic public health.
Administratively, the opportunity was categorized as a discretionary grant in the Education/Health activity area and tied to CFDA 93.279 (Drug Abuse and Addiction Research Programs). The posting date was March 28, 2008, with an original and final closing date of May 7, 2011, and an archive date of June 7, 2011. The full announcement was hosted through the NIH Grants Guide (link provided in the listing), with NIH Office of Extramural Research (OER) contact support for access or technical issues.
Frequently Asked Questions (FAQs): Epidemiology of Drug Abuse (R03) - PA-08-126
What is the purpose of the Epidemiology of Drug Abuse (R03) opportunity (PA-08-126)?
This NIDA/NIH funding opportunity was designed to support small, focused epidemiologic studies that improve understanding of drug abuse in real-world populations. Its central goal was to expand and strengthen population-oriented research that clarifies the nature and extent of drug use and drug use disorders, their consequences, and their causes (etiology).
Which agency offered this funding opportunity?
The announcement was issued by the National Institute on Drug Abuse (NIDA), which is part of the National Institutes of Health (NIH).
What is the Funding Opportunity Number for this announcement?
The Funding Opportunity Number is PA-08-126.
What grant mechanism does this opportunity use?
This opportunity used the NIH Small Research Grant mechanism (R03), which is intended for short-term projects that can be completed with limited resources.
What kinds of projects were encouraged under the R03 mechanism?
The announcement emphasized several common R03 project forms, including:
- Pilot and feasibility studies
- Secondary analyses of existing datasets
- Small, self-contained research projects
- Projects to develop or refine research methods or new research technology relevant to drug abuse epidemiology
What scientific areas or topics were within scope?
The scope was broad and explicitly population-oriented. The opportunity encouraged research that sharpens knowledge about:
- Patterns of drug use and drug use disorders
- Risk factors and protective factors
- Trajectories of drug use and related outcomes over time
- The public health burden and consequences of drug abuse
- How these issues vary across settings and population subgroups
What does "population-oriented" mean in the context of this announcement?
Based on the announcement description, population-oriented work includes studies that examine drug use and related outcomes across individuals and families, and that consider differences by age group, gender, community context, and other population subgroups.
Was the goal to study drug abuse in controlled lab settings or in real-world settings?
The opportunity emphasized epidemiologic studies that improve understanding of drug abuse in real-world populations.
How does this R03 announcement relate to other NIDA opportunities?
This R03 announcement ran in parallel with two companion announcements that shared the same scientific scope but used different grant mechanisms:
- PA-08-124 (R01): for larger, more comprehensive projects
- PA-08-125 (R21): for exploratory or developmental work
Why would an applicant choose the R03 route instead of the R01 or R21 companions?
The R03 mechanism signals projects that are tightly scoped, efficient, and designed to produce useful findings quickly, such as pilots, feasibility work, secondary data analyses, or method/tool development. The R01 and R21 companions offered alternative routes aligned to larger or more exploratory project types.
Were funding amounts and project periods fixed?
No. The announcement did not specify fixed award amounts or a fixed number of awards. NIDA indicated award sizes and project periods would vary because proposals could differ widely in topic, design, duration, and budget needs.
How were final funding decisions expected to be made?
Final funding decisions were expected to depend on factors described in the announcement summary, including the number of applications received, scientific and technical quality, requested duration, and proposed costs.
Was cost sharing or matching required?
No. The announcement stated there was no cost sharing or matching requirement.
Who was eligible to apply?
Eligibility was broad and included many organization types across public, private, nonprofit, and governmental sectors. The listing included (among others):
- Public and private institutions of higher education
- Nonprofits with and without 501(c)(3) status
- Small businesses
- For-profit organizations (other than small businesses)
- State and local governments (including counties, cities/townships, and special districts)
- Independent school districts
- Public housing authorities / Indian housing authorities
- Native American tribal governments and tribal organizations
- HBCUs and Hispanic-serving institutions
- Tribally controlled colleges and universities
- Alaska Native and Native Hawaiian serving institutions
- Faith-based and community-based organizations
- Eligible federal agencies
- Regional organizations
- U.S. territories or possessions
Could non-U.S. (foreign) organizations apply?
Yes. The announcement allowed non-U.S. (foreign) organizations to apply, reflecting the relevance of drug abuse epidemiology to global as well as domestic public health.
What activity area was this opportunity associated with?
The opportunity was categorized as a discretionary grant in the Education/Health activity area.
What CFDA program number was associated with this funding opportunity?
The announcement was tied to CFDA 93.279 (Drug Abuse and Addiction Research Programs).
When was the opportunity posted?
The posting date listed for this opportunity was March 28, 2008.
What were the application closing dates?
The listing stated an original and final closing date of May 7, 2011.
When was the opportunity archived?
The archive date listed was June 7, 2011.
Where could applicants find the full announcement details?
The full announcement was hosted through the NIH Grants Guide (via the link provided in the listing).
Who provided support for access or technical issues related to the announcement?
NIH Office of Extramural Research (OER) contact support was referenced for access or technical issues.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: Enhancing Tumoricidal Activity of Natural Killer (NK) Cells by Dietary Components for Cancer Prevention (R01)
Previous opportunity: Epidemiology Of Drug Abuse (R21)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 08 126
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 08 126) also looked into and applied for these:
| Funding Opportunity |
|---|
| Enhancing Tumoricidal Activity of Natural Killer (NK) Cells by Dietary Components for Cancer Prevention (R01) Apply for PA 08 131 Funding Number: PA 08 131 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Enhancing Tumoricidal Activity of Natural Killer (NK) Cells by Dietary Components for Cancer Prevention (R21) Apply for PA 08 132 Funding Number: PA 08 132 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Prescription Drug Misuse (R01) Apply for PA 08 127 Funding Number: PA 08 127 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Prescription Drug Misuse (R21) Apply for PA 08 128 Funding Number: PA 08 128 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Prescription Drug Misuse (R03) Apply for PA 08 129 Funding Number: PA 08 129 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Exploratory/Developmental Grant for Complementary and Alternative Medicine (CAM) Studies of Humans (R21) Apply for PAR 08 135 Funding Number: PAR 08 135 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Correlative Studies with Specimens from Multi Site Trials (R21) Apply for PA 08 133 Funding Number: PA 08 133 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Correlative Studies with Specimens from Multi Site Trials (R01) Apply for PA 08 134 Funding Number: PA 08 134 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Mitochondria in Cancer Epidemiology, Detection, Diagnosis and Prognosis (R01) Apply for PA 08 143 Funding Number: PA 08 143 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Mitochondria in Cancer Epidemiology, Detection, Diagnosis and Prognosis (R21) Apply for PA 08 144 Funding Number: PA 08 144 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Science Education Drug Abuse Partnership Award R25 Apply for PAR 08 145 Funding Number: PAR 08 145 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Biomarkers of Infection Associated Cancers (R01) Apply for PA 08 156 Funding Number: PA 08 156 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Biomarkers of Infection Associated Cancers (R21) Apply for PA 08 157 Funding Number: PA 08 157 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Transdisciplinary Research on Fatigue and Fatigability in Aging (R01) Apply for PA 08 161 Funding Number: PA 08 161 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Transdisciplinary Research on Fatigue and Fatigability in Aging (R21) Apply for PA 08 162 Funding Number: PA 08 162 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Stem Cells and Cancer (R21) Apply for PA 08 165 Funding Number: PA 08 165 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Economics of Treatment and Prevention Services for Drug Alcohol Abuse (R03) Apply for PA 08 172 Funding Number: PA 08 172 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Economics of Treatment and Prevention Services for Drug Alcohol Abuse (R01) Apply for PA 08 174 Funding Number: PA 08 174 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Novel Lentiviral Models of HIV Neuropathogenesis (R01) Apply for PAS 08 178 Funding Number: PAS 08 178 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Novel Lentiviral Models of HIV Neuropathogenesis (R21) Apply for PAS 08 179 Funding Number: PAS 08 179 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 08 126", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.